Revenue for Neptune Technologies & Bioressources Inc. (NASDAQ.NEPT – TSX.V.NTB) increased for the three-month and nine-month periods ended Nov. 30, 2010, according to consolidated financial results released by the company. Neptune’s nutraceutical revenue also increased during these periods. Consolidated revenue increased by 14% to $4,290,000 for the three-month period ended Nov. 30, 2010, up from $3,758,000 achieved during the corresponding period ended Nov. 30, 2009.
